Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($) $ in Thousands |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Liabilities, Fair Value Disclosure [Abstract] | ||
| Interest rate derivative liabilities, at fair value | $ 991 | $ 0 |
| Current portion of contingent consideration | 0 | 19,573 |
| Total: | 991 | 19,573 |
| Bioness, Inc | ||
| Liabilities, Fair Value Disclosure [Abstract] | ||
| Current portion of contingent consideration | 0 | 19,573 |
| Level 2 | ||
| Liabilities, Fair Value Disclosure [Abstract] | ||
| Interest rate derivative liabilities, at fair value | 991 | 0 |
| Total: | 991 | 0 |
| Level 2 | Bioness, Inc | ||
| Liabilities, Fair Value Disclosure [Abstract] | ||
| Current portion of contingent consideration | 0 | 0 |
| Level 3 | ||
| Liabilities, Fair Value Disclosure [Abstract] | ||
| Interest rate derivative liabilities, at fair value | 0 | 0 |
| Total: | 0 | 19,573 |
| Level 3 | Bioness, Inc | ||
| Liabilities, Fair Value Disclosure [Abstract] | ||
| Current portion of contingent consideration | $ 0 | $ 19,573 |